Raphas Co. Ltd Total Liabilities

Latest as of June 2026: ₩40.43 Billion KRW ≈ $27.40 Million USD

Raphas Co. Ltd total liabilities. Based on the latest financial reports, Raphas Co. Ltd (214260) has total liabilities worth ₩40.43 Billion KRW (≈ $27.40 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Raphas Co. Ltd (214260) asset resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Raphas Co. Ltd (2017–2025)

Total liabilities of Raphas Co. Ltd from 2017 to 2025. This chart illustrates how Raphas Co. Ltd's total liabilities have evolved over time, based on quarterly financial data.

Raphas Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Raphas Co. Ltd ranked by their total liabilities.

Company Country Total Liabilities
Burcelik Vana Sanayi ve Ticaret AS
IS:BURVA
Turkey TL11.43 Million
BIT Computer Co. Ltd
KQ:032850
Korea ₩9.91 Billion
Lustrum Minerals Limited
AU:LRM
Australia AU$-153.34K
NDL Ventures Limited
NSE:NDLVENTURE
India Rs58.64 Million
PCF Group SA
WAR:PCF
Poland zł66.55 Million
Vietnam National Seed Group JSC
VN:NSC
Vietnam ₫1.17 Trillion
Yura Tech. Co. Ltd
KQ:048430
Korea ₩34.46 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Raphas Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Raphas Co. Ltd balance sheet assets.

Liquidity & Leverage Metrics

Raphas Co. Ltd Total Liabilities Ratios Explained

Raphas Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.77 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.58 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.59 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Raphas Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Raphas Co. Ltd (2017–2025)

The table below shows the annual total liabilities of Raphas Co. Ltd from 2017 to 2025.

Year Total Liabilities Change
2025-12-31 ₩44.36 Billion
≈ $30.06 Million
-5.07%
2024-12-31 ₩46.73 Billion
≈ $31.67 Million
-31.37%
2023-12-31 ₩68.10 Billion
≈ $46.15 Million
+23.51%
2022-12-31 ₩55.13 Billion
≈ $37.36 Million
+21.21%
2021-12-31 ₩45.49 Billion
≈ $30.82 Million
+190.71%
2020-12-31 ₩15.65 Billion
≈ $10.60 Million
+3.95%
2019-12-31 ₩15.05 Billion
≈ $10.20 Million
+4.67%
2018-12-31 ₩14.38 Billion
≈ $9.75 Million
+29.90%
2017-12-31 ₩11.07 Billion
≈ $7.50 Million
--

About Raphas Co. Ltd

KQ:214260 Korea Biotechnology
Market Cap
$40.34 Million
₩59.53 Billion KRW
Market Cap Rank
#22489 Global
#1449 in Korea
Share Price
₩7080.00
Change (1 day)
+0.57%
52-Week Range
₩6720.00 - ₩15190.00
All Time High
₩75400.00
About

Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organiza… Read more